| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| AADACL2 | CR201_G0004084 | ENSPPYP00000015897 | ENSPPYP00000023892 | AADACL2 isoform 2. | LPA isoform 1. | 0.625 |
| AADACL2 | CYP4V2 | ENSPPYP00000015897 | ENSPPYP00000017045 | AADACL2 isoform 2. | Cytochrome P450 4V2; Omega-hydroxylase that oxidizes medium-chain saturated fatty acids and polyunsaturated omega-3 fatty acids, and which plays a role in fatty acid and steroid metabolism in the eye. Catalyzes the omega- hydroxylation of medium-chain saturated fatty acids such as laurate, myristate and palmitate in an NADPH-dependent pathway. The substrate specificity is higher for myristate > laurate > palmitate (C14>C16>C12). Acts as a polyunsaturated omega-3 fatty acids hydroxylase by mediating oxidation of docosahexaenoate (DHA) to 22- hydroxydocosahexaenoate. Also produces some 2 [...] | 0.650 |
| AADACL2 | FGA | ENSPPYP00000015897 | ENSPPYP00000016920 | AADACL2 isoform 2. | FGA isoform 1. | 0.537 |
| AADACL2 | HRG | ENSPPYP00000015897 | ENSPPYP00000016087 | AADACL2 isoform 2. | HRG isoform 2. | 0.840 |
| AADACL2 | PLG | ENSPPYP00000015897 | ENSPPYP00000024703 | AADACL2 isoform 2. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.625 |
| AGXT | CR201_G0004084 | ENSPPYP00000014927 | ENSPPYP00000023892 | Serine--pyruvate aminotransferase. | LPA isoform 1. | 0.578 |
| AGXT | HRG | ENSPPYP00000014927 | ENSPPYP00000016087 | Serine--pyruvate aminotransferase. | HRG isoform 2. | 0.860 |
| AGXT | PLG | ENSPPYP00000014927 | ENSPPYP00000024703 | Serine--pyruvate aminotransferase. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.578 |
| APOH | CR201_G0004084 | ENSPPYP00000009611 | ENSPPYP00000023892 | APOH isoform 1. | LPA isoform 1. | 0.781 |
| APOH | FGA | ENSPPYP00000009611 | ENSPPYP00000016920 | APOH isoform 1. | FGA isoform 1. | 0.833 |
| APOH | HPX | ENSPPYP00000009611 | ENSPPYP00000004063 | APOH isoform 1. | Hemopexin; Binds heme and transports it to the liver for breakdown and iron recovery, after which the free hemopexin returns to the circulation. | 0.796 |
| APOH | HRG | ENSPPYP00000009611 | ENSPPYP00000016087 | APOH isoform 1. | HRG isoform 2. | 0.858 |
| APOH | KNG1 | ENSPPYP00000009611 | ENSPPYP00000016088 | APOH isoform 1. | KNG1 isoform 1. | 0.613 |
| APOH | PLG | ENSPPYP00000009611 | ENSPPYP00000024703 | APOH isoform 1. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.770 |
| CR201_G0004084 | AADACL2 | ENSPPYP00000023892 | ENSPPYP00000015897 | LPA isoform 1. | AADACL2 isoform 2. | 0.625 |
| CR201_G0004084 | AGXT | ENSPPYP00000023892 | ENSPPYP00000014927 | LPA isoform 1. | Serine--pyruvate aminotransferase. | 0.578 |
| CR201_G0004084 | APOH | ENSPPYP00000023892 | ENSPPYP00000009611 | LPA isoform 1. | APOH isoform 1. | 0.781 |
| CR201_G0004084 | CYP4V2 | ENSPPYP00000023892 | ENSPPYP00000017045 | LPA isoform 1. | Cytochrome P450 4V2; Omega-hydroxylase that oxidizes medium-chain saturated fatty acids and polyunsaturated omega-3 fatty acids, and which plays a role in fatty acid and steroid metabolism in the eye. Catalyzes the omega- hydroxylation of medium-chain saturated fatty acids such as laurate, myristate and palmitate in an NADPH-dependent pathway. The substrate specificity is higher for myristate > laurate > palmitate (C14>C16>C12). Acts as a polyunsaturated omega-3 fatty acids hydroxylase by mediating oxidation of docosahexaenoate (DHA) to 22- hydroxydocosahexaenoate. Also produces some 2 [...] | 0.457 |
| CR201_G0004084 | F13B | ENSPPYP00000023892 | ENSPPYP00000024425 | LPA isoform 1. | F13B isoform 1. | 0.490 |
| CR201_G0004084 | FGA | ENSPPYP00000023892 | ENSPPYP00000016920 | LPA isoform 1. | FGA isoform 1. | 0.929 |
